ओवेरियन कैंसर
An Audit of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
कहाँ जाना है
इस trial के लिए 1 hospital भारत में मरीज़ ले रहा है।
रजिस्ट्री समरी (तकनीकी)
Peritoneal carcinomatosis is a common event in the natural history of colorectal and other digestive tract cancers. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) provides a promising therapeutic option for highly selected patients with peritoneal carcinomatosis arising from different malignancies such as colorectal cancer, gastric cancer, ovarian cancer, or peritoneal mesothelioma with improvement of both patient survival and quality of life. CRS, i.e., removal of all visible metastatic abdominal and pelvic disease with peritonectomy along with HIPEC (for 90…
Sponsor: Tata Memorial Centre
ClinicalTrials.gov पर NCT02754115
रजिस्ट्री पर आखिरी बार 21 Nov 2024 को अपडेट हुआ · हमने 20 Oct 2026 को पढ़ा